Universal Genetic Testing to Identify Pathogenic Germline Variants in Patients With Cancer
JAMA Oncol
.
2021 Jul 1;7(7):1070.
doi: 10.1001/jamaoncol.2021.1002.
Author
Steven Sorscher
1
Affiliation
1
Department of Oncology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
PMID:
34014264
DOI:
10.1001/jamaoncol.2021.1002
No abstract available
Publication types
Letter
Comment
MeSH terms
Genetic Testing*
Germ Cells
Germ-Line Mutation
Humans
Neoplasms* / genetics